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Abstract
Background: Few intervention programs assist patients and their family caregivers to manage
advanced cancer and maintain their quality of life (QOL). This study examined (i) whether
patient–caregiver dyads (i.e., pairs) randomly assigned to a brief or extensive dyadic intervention
(the FOCUS Program) had better outcomes than dyads randomly assigned to usual care and
(ii) whether patients’ risk for distress and other factors moderated the effect of the brief or exten-
sive program on outcomes.
Methods: Advanced cancer patients and their caregivers (N= 484 dyads) were stratified by
patients’ baseline risk for distress (high versus low), cancer type (lung, colorectal, breast, or
prostate), and research site and then randomly assigned to a brief (three-session) or extensive
(six-session) intervention or control. The interventions offered dyads information and support.
Intermediary outcomes were appraisals (i.e., appraisal of illness/caregiving, uncertainty, and
hopelessness) and resources (i.e., coping, interpersonal relationships, and self-efficacy). The
primary outcome was QOL. Data were collected prior to intervention and post-intervention
(3 and 6 months from baseline). The final sample was 302 dyads. RepeatedmeasuresMANCOVA
was used to evaluate outcomes.
Results: Significant group by time interactions showed that there was an improvement in
dyads’ coping ( p< 0.05), self-efficacy ( p< 0.05), and social QOL ( p< 0.01) and in caregivers’
emotional QOL ( p< 0.05). Effects varied by intervention dose. Most effects were found at
3 months only. Risk for distress accounted for very few moderation effects.
Conclusions: Both brief and extensive programs had positive outcomes for patient–caregiver
dyads, but few sustained effects. Patient–caregiver dyads benefit when viewed as the ‘unit of care’.
Copyright © 2012 John Wiley & Sons, Ltd.
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Introduction
Although advanced cancer has serious detrimental
effects on the quality of life (QOL) of patients and their
family caregivers, few interventions have been devel-
oped to help them cope with advanced disease [1–3].
We identified four randomized clinical trials (RCTs)
conducted with patient–caregiver dyads [4–7] and four
with caregivers alone [8–11]. Some positive interven-
tion effects were found for patients (e.g., less hopeless-
ness, symptom distress, and depression) [6,7,12] and
for caregivers (e.g., less burden, higher sleep quality,
and better QOL) [8,10], but studies often had low
enrollment and high attrition and varied considerably
on the dose of the intervention (i.e., 2–10 sessions).
In a time of limited resources, more research is
needed on what intervention dose (brief versus exten-
sive) is necessary to have a positive effect on outcomes
for advanced cancer patients and their caregivers.
Research also needs to examine if patients’ level of
distress (high versus low) moderates the intervention’s
effect on outcomes. Patients with high distress and their
Copyright © 2012 John Wiley & Sons, Ltd.
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caregivers may benefit from an extensive program that
provides more time to discuss problems and obtain
professional feedback, whereas patients with low
distress and their caregivers may obtain benefits from
a briefer program [9,13].
To our knowledge, no studies have examined inter-
vention dose, risk for distress, and multiple outcomes
in advanced cancer patients and their caregivers. Based
on stress–coping theory [14], this study had two aims:
(i) to determine whether patient–caregiver dyads,
randomly assigned to either a brief or extensive dyadic
intervention (i.e., the FOCUS Program), had better
intermediary outcomes (i.e., less negative appraisals
and increased resources) and better primary outcomes
(i.e., improved QOL) than control dyads receiving only
usual care and (ii) to determine whether risk for distress
and other antecedent factors (e.g., gender, type of
dyadic relationship, and cancer type), moderated the
effect of the brief or extensive program on intermediary
and primary outcomes (see Figure 1).
Methods
Participants
Patients were eligible if they were diagnosed with
advanced breast, colorectal, lung, or prostate cancer (i.e.,
stage III or IV) and were within a 6-month window of
having a new advanced cancer diagnosis, progression
of their advanced cancer, or change of treatment for it.
Eligibility also included a life expectancy of ≥6 months,
aged 21 or older, living within 75 miles of participating
cancer centers, and having a family caregiver willing to
participate. Caregivers were eligible if they were aged
18 or older and identified by patients as their primary care-
giver (i.e., provider of emotional and/or physical care).
Family caregivers were excluded if they were diagnosed
with cancer in the previous year or were receiving cancer
treatment. A power analysis was conducted with PASS
[15] software to determine the sample size needed to
detect medium-sized differences in changes among the
six subgroups (i.e., three arms two risk levels). This
indicated that a final sample of 324 patient–caregiver
dyads was needed for a power of 0.80 at p< 0.05.
Procedures
Eligible dyads were informed about the study by clinic
staff at four cancer centers. Dyads interested in the study
were contacted by research staff and, if willing to partic-
ipate, were scheduled for an initial home visit. During
this visit, participants signed consent forms approved
by Institutional Review Boards at the patient’s cancer
center and the University of Michigan (coordinating
site) and then completed baseline questionnaires.
Patients and caregivers completed questionnaire book-
lets separately, without discussion. At baseline, patients
were screened for their risk for distress using the Risk
for Distress Scale (RFD). Scores of ≥9 on the RFD
were designated high risk on the basis of our previous
research [16]. A stratified randomization process was
used; dyads were stratified by patients’ risk status
(high or low), type of cancer (breast, colorectal, lung,
or prostate), and research site (four sites) and then
randomly assigned in blocks of three to one of three
arms: (i) control condition (usual care); (ii) brief
FOCUS program; or (iii) extensive FOCUS program.
Data were obtained at baseline prior to intervention
(time 1), following the intervention at 3 months after
baseline (time 2) and at 6 months after baseline (time 3).
The brief and extensive programs were delivered in the
home by primarily masters-prepared nurses during
the 3-month interval between baseline and time 2
assessments. Data were collected by a separate team




All study participants received usual care at their cancer
center, consisting of the medical treatment of cancer
and symptom management. Psychosocial support was
provided occasionally but was not delivered routinely
to patients or caregivers.
Experimental condition
The original FOCUS program was a home-based
dyadic intervention that provided information and
Figure 1. Study model
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support to cancer patients and caregivers together, as
the unit of care [7,17]. It addressed five content areas
related to the acronym FOCUS: family involvement,
optimistic attitude, coping effectiveness, uncertainty
reduction, and symptom management. The FOCUS
program was tested in two prior RCTs with positive
outcomes [7,17]. Although prior participants reported
high satisfaction with the program [18], some partici-
pants reported they would have preferred more sessions
while others would have preferred fewer sessions.
To determine the optimal dose of the intervention,
we revised the original five-session program into brief
and extensive versions. The brief FOCUS program
consisted of three contacts (two 90-min home visits
and one 30-min phone session). The extensive FOCUS
program consisted of six contacts (four 90-min home
visits and two 30-min phone sessions). The content of
both programs was the same, but the brief program
was condensed into 3.5 h that required less participant
and staff time. The extensive program was 7 h and
allowed more time for discussion and review of con-
tent. Both programs were 10 weeks in duration, which
enabled the initial post-intervention data collection to
occur at 3 months from baseline for both experimental
and control groups.
Intervention nurses received a 40-h training program.
To maintain intervention fidelity, nurses (i) completed a
protocol checklist for either the brief or extensive
program, (ii) recorded the length of each session in
minutes, and (iii) tape-recorded randomly selected
intervention sessions that were analyzed for adherence
to protocols.
Fifty protocol checklists (25 brief and 25 extensive)
were randomly selected and analyzed for adherence;
95% of all interventions listed in protocols were docu-
mented as implemented. The average length of the
brief (M= 223 min, SD= 65) and extensive programs
(M= 348 min, SD= 104) were significantly different
(p< 0.001). Review of the audio-taped sessions indi-
cated that nurses adhered to both protocol guidelines
with high fidelity.
Instruments
Established instruments were used to measure study
variables in Figure 1. Internal consistency reliability
alphas were assessed at all three administrations and
averaged (aM) (see Table 1).
Risk for distress and other moderators
The risk of developing emotional distress in the future
was measured at baseline with the 77-item RFD,
adapted from the original Omega Clinical Screening
Interview [19]. The RFD assesses demographics, health
history, current concerns, and symptom distress and
provides a composite risk score that ranges from 0 to
23; scores≥ 9 were considered high risk based on our
prior research [16]. Other potential moderators (e.g.,
dyadic relationship and cancer type) were assessed in
a researcher-designed questionnaire.
Appraisal variables
Appraisals of illness and caregiving were assessed with
the Appraisal of Illness Scale (patients) and Appraisal
of Caregiving Scale (caregivers) [20]. Uncertainty
was measured with a brief version of the Mishel Uncer-
tainty in Illness Scale [21]. Hopelessness was measured
with the Beck Hopelessness Scale [22]. Higher scores
indicated more negative appraisals, higher uncertainty,
and more hopelessness.
Resource variables
Coping strategies were assessed with the Brief Cope
[23] factor analyzed into active coping and avoidant
coping strategies consistent with our previous studies
[24,25]. Healthy behaviors were measured with a
researcher-developed scale to assess activities that were
encouraged in the intervention (e.g., exercise, nutrition
and adequate sleep).
Dyadic supportwas measured with a modified version
of the family support subscale of the Social Support
Questionnaire [26]. Communication was measured
with the Lewis Mutuality and Sensitivity Scale [27],
which assessed dyads’ illness-related communication.
Self-efficacy was assessed with the Lewis Cancer Self-
efficacy Scale [27].
Higher scores on coping subscales, healthy beha-
viors, communication, dyadic support, and self-efficacy
indicated higher levels of these factors.
Quality of life
Quality of life was measured with the general Functional
Assessment of Cancer Therapy (version 4), a cancer-
specific instrument that assessed QOL and four
domains: social, emotional, functional, and physical
well-being [28]. To assess how the intervention
impacted QOL, we assessed the subscales of QOL
separately. Caregivers completed a slightly modified
version of the Functional Assessment of Cancer Therapy
that asked caregivers to report on their own QOL [3].
Higher scores indicated better QOL.
Data analysis
The primary analyses for this study were to compare
effects by intervention group. Secondary analyses
examined effects of patient’s risk level, our primary
moderator. Because data involved both members of
the dyad, analyses were performed at the dyad level
(i.e., significant intervention effects would show that
the intervention benefitted the dyad as a whole). In
addition, we assessed possible differences in the effi-
cacy of the intervention between patient and caregivers
by testing interactions of role (patient versus caregiver).
Other key moderators were examined for possible
effects on outcomes. Chi-squared tests and ANOVA
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analyses were conducted to assess for differences
among intervention and control groups at baseline. If
differences were detected, these variables were used
as covariates in subsequent analyses.
To assess intervention efficacy, repeated measures
MANCOVA were conducted. Role was modeled as a
within-subjects effect to account for the possible corre-
lated nature of dyad data. Overall efficacy of the inter-
vention was evaluated by assessing the experimental
group (control, brief, or extensive) time (baseline,
3 months, 6 months) interaction. We assessed the
possible moderating effects of role (patient versus
caregiver) by exploring the experimental group
time role interaction. We assessed the possible mod-
erating effects of level of risk for distress (low or high)
by exploring the experimental group time level of
risk interaction. In addition, we tested for possible
experimental group time role level of risk inter-
action. Possible moderation by gender, type of dyadic
relationship, and cancer type was also examined.
Significant interactions were followed up with simple
effects to examine the nature of the interactions. In or-
der to reduce the number of tests conducted, we used
multivariate analyses and grouped outcomes that were
conceptually related: appraisal variables (appraisal of
illness, uncertainty, and hopelessness), coping vari-
ables (active coping, avoidant coping, and healthy
behaviors), and interpersonal variables (social support
and communication). Self-efficacy was not obviously
grouped with any of the other variables, so it was
assessed by itself. Similarly, the primary outcome
domains of QOL were assessed separately. If the over-
all multivariate analysis was significant, we assessed




Over 4 years, 906 patient–caregiver dyads were
referred to the study; 484 dyads completed baseline
assessments (enrollment rate 68.6%) and were random-
ized; 343 dyads completed time 2 assessments (70.9%
retention); and 302 dyads completed time 3 assess-
ments (62.4% retention) (see Figure 2). At baseline,
there were no significant differences in demographic
(e.g., age, gender, and socioeconomic status) or medi-
cal variables (e.g., cancer type and duration of
advanced disease) among the three arms. There was
no significant differential loss to follow-up among the
three groups at 3 months (w2(N= 484; d.f. = 2) = 0.05,
p= .93) or 6 months (w2(N= 484; d.f. = 2) = 0.26,
p= .88). No differences were found between patients
or caregivers lost to follow-up and those retained in
the study on demographic, medical, stratification, or
baseline study variables (all p> .05).
The average age of patients in the final sample was
60.5 years (SD= 10.9; range 26–87); for caregivers, it
was 56.7 (SD= 12.6; range 18–88). Education averaged
14.8 years for patients and caregivers (SD= 2.7; range
8–22 years). Racial composition was 82.5% Caucasian,
13.5% African-American, 1% Hispanic, 1.3% American
Indian, 1.3% Asian, and 0.3% multi-racial. The majority
of patients (61.4%) and caregivers (55.8%) were female.
Most caregivers were spouses (74%). At baseline,
approximately half of the patients were at high risk for
distress (56%).
Most patients had breast cancer, followed by lung,
colorectal, and prostate cancer (see Figure 2). The
average time since original diagnosis was 47 months.
Sixty-six percent were currently receiving chemotherapy,
23% hormones, 8% radiation, 4% surgery, and 6%
followed with watchful waiting (multiple responses were
possible). Patients (72%) and caregivers (66%) had
comorbid conditions, most commonly hypertension and
heart problems. The groups did not differ significantly
on changes in treatment or progression of disease (all
p-values> 0.05), indicating no potential confound of
treatment change by condition.
Despite randomization, group differences can emerge.
Therefore, we examined differences among the three
groups at baseline. Baseline differences were found for
patient appraisal, patient uncertainty, patient and care-
giver hopelessness, patient communication, and patient
and caregiver dyadic support (all p-values< 0.05). These
variables were controlled for in all subsequent analyses.
Major study outcomes
Table 1 provides adjusted means for patients and
caregivers in the three groups at baseline, 3-month,
and 6-month assessments, controlling for the variables
that differed among groups at baseline. There were no
differential changes among groups on appraisal vari-
ables (appraisal of illness, uncertainty, and hopeless-
ness) and interpersonal variables (communication and
dyadic support). However, there was a significant
group time effect on coping variables, F= 2.15,
p= 0.013. Univariate analyses showed that this was pri-
marily because of effects on avoidant coping, F= 2.53,
p= 0.039, and healthy behaviors, F= 2.67, p= 0.031.
Simple effects showed that control dyads’ avoidant
coping did not change significantly from baseline to
3-month or 6-month follow-ups. In contrast, dyads in
the extensive group (p= 0.001) and brief group
(p= 0.033) had a significant decrease in their use of
avoidant coping from baseline to 3 months. This signif-
icant effect was maintained only for dyads in the brief
group at 6 months (p= 0.045). For healthy behaviors,
there were no significant changes for control or exten-
sive dyads at 3-month or 6-month follow-ups. However,
brief dyads showed a significant increase in their use of
healthy behaviors at 3 months (p= 0.001), but it was not
maintained at 6 months.
Also, there was a significant group time effect
on self-efficacy, F= 2.84, p = 0.024. Simple effects
showed that control and brief dyads’ self-efficacy did
not change significantly from baseline to 3-month or
6-month follow-ups. In contrast, extensive dyads’
558 L. L. Northouse et al.
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self-efficacy significantly increased at 3 months
(p= 0.041), but was not maintained at 6 months.
There was a significant group time effect for social
QOL, F= 4.28, p= 0.002. Simple effects showed that
control dyads had a significant decline in their social
QOL at 3 months (p= 0.001), whereas extensive and
brief dyads maintained their social QOL at 3-month
and 6-month follow-ups. Table 2 summarizes the sig-
nificant group time effects for dyads.
Moderator effects
We found a group time role interaction for emo-
tional QOL, F= 2.50, p= 0.042. Simple effects showed
that for patients, there was a significant increase in emo-
tional QOL for control, extensive, and brief patients at
the 3-month follow-up (all p-values< 0.05). However,
for caregivers, there was no significant change in con-
trol caregivers’ emotional QOL at 3-month and 6-month
follow-ups, whereas there was a significant increase in
extensive and brief caregivers’ emotional QOL at
3 months (all p-values< 0.01), which was sustained to
6-month follow-ups (all p-values< 0.05).
We also found a group time risk interaction for
the interpersonal variables, F= 2.66, p= 0.007. Inspec-
tion of the univariate effects showed that this was
driven primarily by differences in dyadic support,
F= 2.72, p= 0.029. Simple effects showed that low risk
control dyads’ social support significantly decreased at
the 3-month (p= .036) and 6-month (p=0.003) follow-
ups. However, this decrease was not observed in the high
risk control, extensive, or brief dyads.
We found a group time risk role interaction
for the interpersonal variables, F= 1.99, p = 0.045.
Inspection of the univariate effects showed that this
was primarily for communication, F= 2.72, p = 0.029.
Simple effects showed no changes for patients regard-
less of risk level and intervention condition. However,
low risk caregivers in the control group showed a
significant decrease in communication at 3-month
(p= 0.010) and 6-month (p= 0.014) follow-ups. The
high risk control, extensive, and brief caregivers did
not change in their communication.
We also examined whether type of dyadic relation-
ship (spouse versus non-spouse), cancer type (four
types), and gender moderated the effect of the interven-
tion on outcomes. No moderation effects were found.
Table 2. Summary of significant effects for patient–caregiver dyads
Group Control Brief Extensive
Assessment 3 months 6 months 3 months 6 months 3 months 6 months
Avoidant coping — — # # # —
Healthy behaviors — — " — — —
Self-efficacy — — — — " —
Social QOL # — — — — —
Emotional QOL — — "a "a "a "a
aEffects for caregivers only.
Figure 2. Flow through randomized clinical trial
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Discussion
Intervention dose and outcomes
We examined the effects of two doses of the FOCUS
intervention on outcomes for advanced cancer patients
and their family caregivers. Intervention effects were
limited in number and duration; most effects occurred
at 3-month follow-up only, just after completion
of the intervention. Nevertheless, patients and their
caregivers who participated in the brief or extensive
FOCUS programs had more improvement on study
outcomes than dyads in the control group (see Table 2).
Because the brief and extensive programs had nearly
the same number of effects, we cannot say that one
intervention dose was better than the other for dyads
facing advanced cancer. Instead, findings suggest that
the optimal intervention dose may depend on which out-
come is targeted for change. The extensive six-session
program significantly improved dyads’ self-efficacy or
confidence in their ability to manage the illness and the
caregiving associated with it, suggesting that longer
interventions may be needed to improve self-efficacy.
The brief three-session program, on the other hand,
was sufficient to improve both caregivers’ and patients’
use of healthy behaviors (nutrition and exercise) during
a time when caregivers often neglect their own health,
while the patient’s condition is deteriorating. Both the
extensive and brief programs helped dyads cope more
effectively by decreasing their use of avoidant coping
(i.e., denial), which is often related to poorer adjustment
to cancer [24]. Both programs also helped dyads main-
tain their social quality of life (i.e., support from family
and friends).
We found a significant time group role effect
on emotional QOL for brief and extensive caregivers
at 3-month and 6-month follow-ups, but no change
for control caregivers. Including caregivers in the inter-
vention made it possible for them to address their own
concerns, receive support, and improve their emotional
QOL. Brief and extensive patients also had an increase
in their emotional QOL, but since this improvement
occurred in control patients also, the change cannot
be attributed to the interventions. It is possible that
advanced cancer patients, in general, perceive more
emotional support from others including clinic staff,
which helps to improve their emotional QOL. Their
caregivers, on the other hand, seldom perceive support
from others [29] and, hence, appear to derive more
benefit from the interventions. It is also possible that
completing baseline surveys may have sensitized con-
trol patients to address their emotional needs.
We found no intervention effects for appraisal vari-
ables (e.g., uncertainty). It may be difficult to reduce
dyads’ negative appraisals during advanced cancer, as
the disease progresses and cure is not possible. How-
ever, in our prior RCTs with dyads facing recurrent
breast cancer [7] and with couples facing newly diag-
nosed and advanced prostate cancer [17], we did obtain
a significant improvement on appraisal variables. The
lack of effect in this study may be due to the sizeable
number of dyads dealing with advanced lung cancer,
which is often viewed as a more threatening and rapidly
progressing cancer than breast or prostate cancer [13].
While some positive intervention effects were
found, the effects on most outcomes were not sustained
at 6-month follow-up. It may be more difficult to
sustain intervention effects as the patient’s illness
progresses and demands on caregivers increase. Pro-
grams that are incorporated into standard to provide
ongoing information and support for dyads’ changing
needs may be more effective in sustaining intervention
effects. The lack of sustained effects may also be
related to the decrease in our sample size at 6 months.
By 6 months, 16% of the patients had died, and others
were too ill to complete questionnaires. Our final
sample at 6 months was 302 dyads instead of our target
of 324 dyads; hence, our power was lower (0.75–0.76)
than desired (0.80) for these analyses, making it diffi-
cult to detect small intervention effects if they existed.
Risk status and outcomes
This study also examined if patients’ baseline risk for
distress (high or low) had a differential effect on out-
comes for patient–caregiver dyads. We expected that
high risk patients and their caregivers would benefit
more from the extensive program, but that was not
the case. Patients’ initial risk for distress moderated
only two outcomes, and both pertained to interpersonal
variables with participants in the control group. Specif-
ically, low risk dyads in the control group reported a
significant decrease in their dyadic support, and low
risk control caregivers reported a significant decrease
in their dyadic communication. It is possible that low
risk control dyads perceived less of a need to offer
one another support or engage in illness-related com-
munication. In contrast, brief and extensive dyads
may have attended to their interpersonal relationships,
which was encouraged in intervention programs,
and were able to maintain their dyadic support and
communication, especially from the perception of the
caregiver.
The limited moderation effects by risk status may
suggest that just because dyads are identified at high
risk for poorer outcomes, it does not necessarily mean
they will obtain more benefit from a time-limited
program than low risk dyads. Patients and caregivers
may need some basic personal, social, and/or economic
resources to benefit from a time-limited intervention
(18). Since only two studies to our knowledge have
examined risk status and outcomes during advanced
cancer [5,11] and neither study found intervention
effects for these high risk families or caregivers in their
primary analyses, the relationship between high risk
status and intervention outcomes is not clear and needs
further research.
There are limitations to this study. First, only
patients’ risk status (i.e., high versus low) were used
as a stratification variable, assuming they were more
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likely to be assessed in practice settings. Findings may
have differed if a combined patient–caregiver risk score
had been used or if patients’ actual risk scores had been
used (a continuous variable) instead of their high/low
risk status (a categorical variable). Second, we mea-
sured risk for distress instead of current distress, which
may have affected the findings. Third, it would have
been beneficial if we had collected information on
patients’ performance status over time, which may have
helped explain the study findings.
This study has implications for practice. Findings
suggest that when interventions are offered to advanced
cancer patients and their family caregivers together
as the unit of care, both individual’s coping ability,
self-efficacy, and aspects of their QOL can bemaintained
or even improved. In current practice, only patients’
needs are routinely addressed; caregivers often are left
on their own to obtain information and support to deliver
complex care in the home. Our findings also indicate
that shorter interventions requiring less professional
resources may achieve some of these outcomes.
Research challenges that remain include the following:
identifying ways to help high risk patients and their
caregivers, targeting interventions to address dyadic
needs as well individual needs of patients and caregivers,
determining how to implement dyadic interventions in
practice settings, finding ways to sustain positive inter-
vention effects, and developing modes of delivery (e.g.,
the Internet) that will enable more patients and caregivers
to benefit from psychosocial interventions at a lower cost.
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